UsAgainstAlzheimer's Blog

Stay up to date on the latest from UsAgainstAlzheimer's on our blog. Read about what our team is working on, the latest advancements in research, and what you can do to join the fight.

Working with UsAgainstAlzheimer’s and Voices of Alzheimer’s, Jay Reinstein takes you with him to better understand a day in the life of someone living with Alzheimer’s.

View Jay's Journal.

November 13, 2025

Alzheimer’s Awareness Month Blog | 
Fact vs. Fiction: Why Early Detection of Alzheimer’s Matters

Alzheimer’s Awareness Month Blog
Fact vs. Fiction: Why Early Detection of Alzheimer’s Matters This Alzheimer’s Awareness Month brings both reflection and hope. The FDA’s recent approval of the first blood test that can help primary care providers rule out Alzheimer’s marks another step forward in how we understand and detect this disease. 
 This milestone reinforces a critical truth: early detection matters. Alzheimer’s begins years—even decades—before noticeable symptoms appear. The sooner we recognize and understand what’s happening in the brain, the more options people have to take control of their health, plan for the future, and participate in research that can
November 08, 2024

Centers for Medicare and Medicaid Services: Appropriately cover the costs of blood tests helping to detect Alzheimer’s

UsAgainstAlzheimer’s, along with a coalition of leading advocacy groups, is calling for the Centers for Medicare and Medicaid Services (CMS) to appropriately cover the costs of blood tests helping to detect Alzheimer’s. October 25, 2024 Meena Seshamani, MD, PhD Deputy Administrator and Director, Center for Medicare Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Dr. Seshamani: RE: CY 2025 Clinical Laboratory Fee Schedule Preliminary Determinations: Category 1 CPT®[1] Codes and Assays for Fluid-Based Amyloid Beta and Tau Protein Biomarkers Alzheimer’s disease and related dementias are only diagnosed about half of the time. The pathology is detected
September 15, 2024

Celebrating Hispanic Heritage Month: A Latino Cookbook for Brain-Healthy Eating

Alzheimer’s disease disproportionately affects the Latino community, with rates expected to skyrocket in the coming years. Research shows that diet plays a crucial role in reducing the risk of cognitive decline, and the flavorful foods in many Latino diets—like leafy greens, fruits, and whole grains—are packed with antioxidants and essential nutrients that support brain health. Honoring Tradition, Promoting Brain Health As we celebrate the vibrant culture, art, and history of Hispanic heritage, we’re also embracing a future where health and tradition go hand in hand. This Latino cookbook is a resource for families seeking to enjoy delicious meals while taking
August 09, 2024

Enhancing Brain Health and Reducing Dementia Risk - Key Recommendations from the NAPA Advisory Council

The National Alzheimer's Project Act (NAPA) Advisory Council recently convened to discuss strategies for mitigating dementia risk factors across the lifespan. Here are the key recommendations presented by the Risk Reduction Subcommittee tasked with implementing Goal 6 of our nation’s plan to address Alzheimer’s: Accelerate Action to Promote Healthy Aging and Reduce risk Factors for Alzheimer’s Disease and Related Dementias . UsAgainstAlzheimer’s worked with hundreds of organizations to add Goal 6 to the National Pan . These recommendations are conveyed to the Secretary and to Congress. Identify and Track Priorities: Reauthorize NAPA for another ten years. Focus on Six Key
June 06, 2024

More Evidence that “What’s Good for the Heart is Even Better for The Brain” in early-stage Alzheimer’s patients

New study demonstrates how diet, exercise, and other interventions improved brain cognition and function after just 20 weeks Imagine being able to fight the effects of Alzheimer’s, not with a pill, but by making changes to the way you live your daily life? That’s what Dr. Dean Ornish of the Preventive Medicine Research Institute set out to research in a randomized controlled clinical trial and the results were astonishing. In a study published in Alzheimer’s Research and Therapy on June 7, 2024, Ornish and his colleagues found that after 20 weeks of an intensive lifestyle intervention, some patients with mild